Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1326 participants
OBSERVATIONAL
2004-02-29
2006-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ICD
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients or legal guardians who are willing and able to sign a Permission for Access to and Use of Health Information in a Registry Form and, if required by an Institution's IRB, an Informed Consent.
* New or replacement implants of Medtronic market released single, dual or triple chamber ICDs including: GEM VR, GEM DR, GEM III AT, Marquis VR, Marquis DR, Maximo DR, Maximo VR, InSync ICD, InSync Marquis ICD and InSync II Marquis ICD.
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medtronic
INDUSTRY
Medtronic Cardiac Rhythm and Heart Failure
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alfred Buxton, MD
Role: PRINCIPAL_INVESTIGATOR
Rhode Island Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Little Rock, Arkansas, United States
Fountain Valley, California, United States
Poway, California, United States
Sacramento, California, United States
Santa Ana, California, United States
Boulder, Colorado, United States
Bradenton, Florida, United States
Lakeland, Florida, United States
Lauderdale Lakes, Florida, United States
Palm Beach Gardens, Florida, United States
Panama City, Florida, United States
Pembroke Pines, Florida, United States
Tampa, Florida, United States
Atlanta, Georgia, United States
Gainesville, Georgia, United States
Chicago, Illinois, United States
Crown Point, Indiana, United States
Noblesville, Indiana, United States
Monroe, Louisiana, United States
Annapolis, Maryland, United States
Glen Burnie, Maryland, United States
Boston, Massachusetts, United States
Detroit, Michigan, United States
Kalamazoo, Michigan, United States
Columbia, Missouri, United States
Omaha, Nebraska, United States
Newark, New Jersey, United States
Pomona, New Jersey, United States
Brooklyn, New York, United States
Mineola, New York, United States
Williamsville, New York, United States
Charlotte, North Carolina, United States
Minot, North Dakota, United States
Cincinnati, Ohio, United States
Cleveland, Ohio, United States
Kettering, Ohio, United States
Lancaster, Pennsylvania, United States
Langhorne, Pennsylvania, United States
Providence, Rhode Island, United States
Austin, Texas, United States
Fort Worth, Texas, United States
Houston, Texas, United States
McAllen, Texas, United States
Fredericksburg, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
231
Identifier Type: -
Identifier Source: org_study_id